CERTIFICATION

I, Simcha Edell, certify the following:

1.       I have reviewed this annual report on Form 10-KSB of Amazon Biotech,
         Inc.;

2.       Based on my knowledge, this annual report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this annual report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this annual report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of Amazon Biotech, Inc. as of, and for, the periods
         presented in this annual report;

4.       Amazon Biotech, Inc.'s other certifying officer and I are responsible
         for establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Amazon
         Biotech, Inc. and we have done the following:

         a.       designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  our supervision, to ensure that material information relating
                  to Amazon Biotech, Inc., including its consolidated
                  subsidiaries, is made known to us by others within those
                  entities, particularly during the period in which this annual
                  report is being prepared;

         b.       designed such internal control over financial reporting, or
                  caused such internal control over financial reporting to be
                  designed under our supervision, to provide reasonable
                  assurance regarding the reliability of financial reporting and
                  the preparation of financial statements for external purposes
                  in accordance with generally accepted accounting principles;

         c.       evaluated the effectiveness of Amazon Biotech, Inc.'s
                  disclosure controls and procedures and presented in this
                  annual report our conclusions about the effectiveness of the
                  disclosure controls and procedures, as of the end of the
                  period covered by this report based on such evaluation; and

         d.       disclosed in this annual report any change in Amazon Biotech,
                  Inc.'s internal control over financial reporting that occurred
                  during Amazon Biotech, Inc.'s fourth fiscal quarter that has
                  materially affected, or is reasonably likely to materially
                  affect, Amazon Biotech, Inc.'s internal control over financial
                  reporting; and

5.       Amazon Biotech, Inc.'s other certifying officer and I have disclosed,
         based on our most recent evaluation of internal control over financial
         reporting, to Amazon Biotech, Inc.'s auditors and the audit committee
         of the Amazon Biotech, Inc.'s board of directors:


<PAGE>

         a.       all significant deficiencies and material weaknesses in the
                  design or operation of internal control over financial
                  reporting which are reasonably likely to adversely affect
                  Amazon Biotech, Inc.'s ability to record, process, summarize
                  and report financial information; and

         b.       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in Amazon
                  Biotech, Inc.'s internal control over financial reporting.


November 14, 2006                             /s/ Simcha Edell
                                              ----------------------------------
                                              Simcha Edell
                                              Chief Financial Officer
                                              (Principal Financial Officer)